Israel Business Currents
SEE OTHER BRANDS

Fresh news on business and economy in Israel

Israel Business Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Business Currents.

Press releases published on April 14, 2025

StoreDot Boosts its IP Portfolio with Strategic 'StoreDot XFC Shield' Patents

StoreDot Boosts its IP Portfolio with Strategic 'StoreDot XFC Shield' Patents

StoreDot Secures IP Fortress with "XFC Shield" Patents, Driving Adoption of Ultra-Fast Charging for Electric Vehicles HERZELIYA, ISRAEL, April 14, 2025 /⁨EINPresswire.com⁩/ -- StoreDot, the pioneer of extreme fast charging (XFC) battery technology for …

Unibeam Stops AI-Powered Fraud with SIM-Based Deterministic Authentication

Unibeam Stops AI-Powered Fraud with SIM-Based Deterministic Authentication

Unibeam today announced the launch of the world’s first SIM-based deterministic authentication system designed to meet the challenge of AI-powered fraud. TEL AVIV, ISRAEL, April 14, 2025 /⁨EINPresswire.com⁩/ -- Generative AI is accelerating the pace and …

Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares

Can-Fite Announces $3.0 Million Registered Direct Offering of American Depositary Shares

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases (“Can-Fite” or the …

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships

Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced …

Can-Fite Reports 2024 Financial Results and Clinical Update

Can-Fite Reports 2024 Financial Results and Clinical Update

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …

Enlight Raises a Total of $1.5 Billion in Project Finance Following its Third U.S. Financial Close Within Four Months

Enlight Raises a Total of $1.5 Billion in Project Finance Following its Third U.S. Financial Close Within Four Months

The financial close for Quail Ranch includes $243 million of construction loans; COD is expected towards the end of 2025 Enlight’s three U.S. projects now under construction have a combined capacity of 1.4 FGW and are projected to generate total annual …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service